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The 2-oxoglutarate dehydrogenase complex was succinylated using 2-oxo[5-14C]glutarate in the presence of 
N-ethylmaleimide to label the lipoic acid cofactor of the transuccinylase (E2) component. Following peptic 
digestion, 14C-lipoate-containing peptides were purified and subjected to automated Edman degradation 
and amino acid analysis. The amino acid sequence surrounding the lipoyllysine residue is reported. 
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1. INTRODUCTION 
The 2-oxoglutarate dehydrogenase complex is 
one of three multi-enzyme 2-oxoacid dehydro- 
genases present in mammalian mitochondria [ 11. 
The complex catalyses the oxidative decarboxyla- 
tion of 2-oxoglutarate to succinyl CoA, a key reac- 
tion of the tricarboxylic acid cycle. The activity of 
OGDC is regulated by allosteric mechanisms and is 
subject to acute hormonal control, primarily via 
alterations in the intra-mitochondrial levels of free 
Ca’+ [2]. 
OGDC is composed of multiple copies of three 
component enzymes. A thiamine pyrophosphate- 
dependent 2-oxoglutarate dehydrogenase (El) and 
an FAD-linked lipoamide dehydrogenase (E3) are 
each bound non-covalently to a central, sym- 
metrical core consisting of 24 succinyl transferase 
(E2) polypeptides [3]. E2 has an essential cofactor, 
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lipoic acid, which is covalently bound to a flexible 
region of the E2 polypeptide, allowing interaction 
with the active sites of the individual components 
of the complex [3,4]. 
Although the genes encoding the constituent 
polypeptides of OGDC from E. coli have been 
cloned and sequenced and the protein sequence 
deduced [5,6], no sequence data is available for the 
mammalian complex. The amino acid sequence 
surrounding the lipoyllysine site of the mammalian 
PDC has been determined [7] and here we report 
the primary structure surrounding the lipoic acid 
attachment site on E2 of OGDC from bovine 
kidney. 
2. MATERIALS AND METHODS 
Hydroxyapatite (HTP) was from BioRad, pep- 
sin from Boehringer and 2-oxo-[5-14C]glutaric acid 
from Amersham International. 
OGDC was purified from bovine kidney cortex, 
using essentially the method described in [8], ex- 
cept that the gel filtration step was omitted. In- 
stead, contaminating PDC was removed by 
adsorption chromatography. OGDC was applied 
to an hydroxyapatite column (1.6 x 6 cm) 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/87/$3.50 0 1987 Federation of European Biochemical Societies 211 
Volume 222, number 1 FEBSLETTERS September 1987 
equilibrated in 10 mM potassium phosphate, 
1 mM dithiothreitol, pH 7.3, which was then 
washed extensively with 150 mM potassium 
phosphate buffer (500 ml) to remove PDC. OGDC 
was eluted using 500 mM potassium phosphate 
buffer and further pur&d and concentrated by 
ultracentrifugaliun at 244m x g for 2.5 h. A&vi- 
ty cE UGUC was determined by motitotiag tire 
production of NADH spectrophotometrically at 
340 nm [9]. 
Peptic digestion of succinylated OGDC and 
puriii’rcation 01Ytpuk a&&corttaitig pe@ks were 
carried out as in [7], high-voltage electrophoresis 
beirg performed ar pH I.9in 7% ~‘.Y/Y~ fxmk acid 
and HPLC using TSK DEAE 3SW ion-exchange 
and Vydac Cl8 reverse-phase columns. Automated 
amino acid sequencing was carried out on an Ap- 
plied Biosystems 477 pulsed-liquid-phase se- 
quencer with on-line PTH analyser. Amino acid 
compositions were determined using an Applied 
Biosystems 420A derivatiser equipped with on-line 
13OA analyser . 
3. RESULTS AND DISCuSsloN 
Incubation of homogeneous OGDC with 2-0x0- 
[5-14C]glutarate r sulted in the reductive acylation 
of the lipoic acid cofactor of the E2 (transsuc- 
cinffase) commz& 28 tie zkzn@zzX. TZti k- 
termediate was stabilised by treatment with 
N-&,$~~k~~lde, which casxd e&&mte-i~~ 
inactivation of the complex (fig.1). No significant 
loss 02 OGDC aczivjry was DbsmVe 51 jm-sb2iDm 
lacking 2-oxoghttarate or iV-ethylmaleimide (not 
shown]. Maximum incorporation of succinyl 
groups was approx. 2.7 nmol/mg OGDC, COT- 
respondmg to 0.33 moVm01 of E2 p0Imidc. 
This 1ow sroictiomerry is cons&en1 with prtious 
obsm&&s {re] +& has m ta be &IQ expkkd. 
Similar substoichiometric labelling of OGDC using 
3-methyl-[2-‘4C]oxobutyrate has also been 
reported (111. 
High-voltage electrophoresis and autoradio- 
graphy of a peptic digest of “C-succin$ated 
OGDC yielded a single radioactive band of mobili- 
ty approx. 0.24 relative to that of serine. The 
radioactive material was then subjected to ion- 
excka. HPLC , #fc c&XSx lvzcrrg eq;U;~ih&C! <cc 
30 mM imidazole/HCl, pH 6.0, and peptides 
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Fig. 1. Succinylation of OGDC with 2-0x0- 
[5-14C]glutarate in the presence of N-ethylmaleimide. 
OGDC (2 mg/ml) was incubated at 4°C in 0.5 ml 
sodium phosphate buffer, pH 7.4, containing 0.4 mM 
thiamine pyrophosphate, 2 mM MgC12, 0.5 mM N- 
ethylmaleimide and 0.2 mM 2-oxo-[5-14C]glutarate 
(4.8 x 104 cpm/nmol). At the indicated times, aliquots 
We”P% rePXW& %X &&zX?~L%?kkX?~ z=$ %?X?mf& Y&~=L+&=j ‘c-) 
and protein-bound radioactivity (oj PI. 
eluted with a linear gradient (O-400 mM) of_NaCl 
in the same buffer. This resolved the radioactivity 
&&2I a nzi&z @) ti B n2Sniz @3) @, zizi2@&~ 
75 and 15% of the recovered counts respectively. 
Pe#kks A ati B were fUf-&ec pcrriflsd ty rev-- 
phase HPLC [7], each eluting from the reverse- 
#XXX ~D!KXiBlJB 23 2 eSiI&E JIGsjDY @ Ds X&DiS- 
tivity (not shown). However the yield from the first 
column was low, as the majority (&?Yu) of the ap- 
plied radioactivity was unretarded by the column. 
Antiy3is r33 I&s maieri~ by Zrig’h-vokige eke- 
Crophoresis iadicated chat il was acidic ia nature 
a@ &e@ tu k sQiek&e derked fmm &e SK- 
cinylated lipoic acid under the acidic conditions of 
the chromatography. 
The results of automated sequence determiua- 
tion of peptides A and B are shown in table 1. No 
residue was detected at positions 5 and 2 respec- 
tively in peptides A and B. However, amino acid 
analysis indicated the presence of a single lysine 
residue in each peptide (table 2), which was not 
o3zX at ~~~ F&&3X ‘&x&g &e wUrXr&X fX@s. 
Furthermore, as observed previously for the lipoyl 
Volume 222, number 1 FEBS LETTERS 
Table 1 
Amino acid sequence of OGDC lipoyl-peptides 
1 5 10 15 
A: Ile-Glu-Thr-Asp-Lysa-Thr-Ser-Val-Gln-Valsn-Gly 
B: Asp-Lysa-Thr-Ser-Val-Gln-Val-Pro-Ser-Pro-~a-Asn-Gly 
a Denotes lipoyllysine residue 
Table 2 
Amino acid composition of OGDC lipoyl-peptides 
Peptide 
Asx 
GlX 
Ser 
Gly 
Thr 
Ala 
Pro 
Val 
Ile 
Lys 
Total 
A B 
2.34 (2) 1.93 (2) 
1.76 (2) 1.02 (1) 
1.83 (2) 1.87 (2) 
1.05 (2) 1.6 (1) 
1.8 (2) 1.11 (1) 
0.99 (2) 1.05 (1) 
1.94 (2) 1.93 (2) 
2.05 (2) 1.58 (2) 
0.92 (1) 0 (0) 
1.13 (1) 1.23 (1) 
16 13 
Peptides A (600 pmol) and B (75 pmol) were hydrolysed 
in the vapour phase with 6 M HCl under nitrogen 
atmosphere at 110°C for 24 h. Amino acids are listed in 
their order of elution from the reverse-phase column 
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peptides derived from PDC [7], the lysine residue 
to which the lipoic acid is attached is not identified 
by the sequencer. On this basis it is concluded that 
lipoyllysine is the residue at position 5 and 2 in 
peptides A and B, respectively. No significant 
radioactivity was recovered in any fraction from 
the sequencer un, again presumably reflecting in- 
stability under acid conditions of the succinyl 
group attached to the lipoic acid moiety. 
The sequence around the lipoate residue in 
OGDC shows considerable homology with the 
equivalent region in 2-oxoacid dehydrogenase 
complexes from several different sources and with 
the H-protein of the glycine-cleavage enzyme 
system, which also utilises lipoic acid as a co-factor 
in its catalytic mechanism (table 3). There is at 
least 50% identity with the corresponding regions 
from the 2-oxoacid dehydrogenases and 3 1 Q7o iden- 
tity with the H-protein. The homology between the 
2-oxoacid dehydrogenase sequences is particularly 
Table 3 
Amino acid sequences flanking lipoyllysine residues 
Source Enzyme Sequence % identity 
Bovine kidney” OGDC E2 Ile-Glu-Thr-Asp-Lysb-Thr-Ser-Val-Gln-Val-Pro-Ser-Pro-Ala-Asn-Gly 
E. coli [6] OGDC E2 Ile-Glu-Thr-AsD-Lvsb-Val-Val-Leu-Glu-Valla-Ser-~Asp-~ 56 
E. cofi [12] PDC E2 Val-~Gly-AsD-Lvsb-Ala-~Met-Glu-Val-Pro-Ala-~Phe-Ala-~ 56 
SeJ Gln 
Bovine heart [7] PDC E2 Val-Glu-Thr-Asn-Lvsb-Ala-Thr-MGly-Phe 50 
Be 
Chicken liver [13] Glycine- 
cleavage 
H-protein Leu-~Ser-Val-~Ala-Ala-Ser-Glu-Leu-Tyr-Ser-Pro-Leu-Thr-~ 31 
a This work 
b Lipoyllysine residue 
Residues identical to those in the bovine kidney OGDC E2 are underlined 
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striking in the region immediate to the N-terminal 
side of the lipoyllysine residue, indicating that this 
may be a recognition site for the enzyme responsi- 
ble for attachment of the lipoic acid onto the 
polypeptide chain. The finding of a unique lipoate- 
containing sequence for OGDC is consistent with 
the presence of a single lipoate-containing domain 
in each E2 polypeptide. The low stoichiometry of 
succinylation may be due to incomplete modifica- 
tion, possibly due to the lack of coupling of each 
lipoic acid to an active site on El, or due to the ap- 
parent instability of the succinyl group on the 
lipoic acid. Alternatively it is possible that each 
potential site on E2 is not occupied by a lipoic acid 
residue. In this regard it is of interest that it has 
been reported that E2 contains less than a full com- 
plement of lipoic acid [lo]. 
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